InMed Pharmaceuticals Inc. (INM) Reports Q2 Loss, Tops Revenue Estimates

InMed Pharmaceuticals Inc. (INM) delivered earnings and revenue surprises of -29.17% and 6%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for…